1. A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate. Issue 7 (10th February 2012) Authors: Mease, P; Strand, V; Shalamberidze, L; Dimic, A; Raskina, T; Xu, Li-An; Liu, Y; Smith, J Journal: Annals of the rheumatic diseases Issue: Volume 71:Issue 7(2012) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗